Skip to main content
SpringerLink
Log in

Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Serum chemistry and bone morphometry of the proximal tibial metaphysis were performed in 3-month-old double fluorescent-labeled, female Sprague-Dawley rats subjected to bilateral ovariectomy or sham surgery for 4 months prior to treatment with 0, 0.3, 1, 3, or 6 mg of prostaglandin E2 (PGE2)/kg/day subcutaneously for 30 days. The 4-month postovariectomized rats possessed an osteopenic proximal tibial metaphysis with 7% trabecular area compared with controls (19%). PGE2 treatment elevated osteocalcin levels and augmented proximal tibial metaphyseal bone area in ovariectomized and sham-operated rats. Osteopenic, ovariectomized rats treated with 6 mg PGE2/kg/day for 30 days restored bone area to levels of agematched sham-operated rats. Morphometric analyses showed increased woven and lamellar bone area, fluorescent-labeled perimeter (osteoblastic recruitment), mineral apposition rate (osteoblastic activity), bone formation rate (BFR/BV), and longitudinal bone growth. These dramatic bone changes were all significantly increased at the doseresponse manner. This study showed that in vivo PGE2 is a powerful activator of bone remodeling, it increases both bone resorption and bone formation, and produces an anabolic effect by shifting bone balance to the positive direction. Furthermore, PGE2-induced augmentation of metaphyseal bone area in ovariectomized rats was at least two times greater than in sham-operated rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bromley RG, Dockum NL, Arnold JS, Jee WSS (1966) Quantitative histological study of human lumbar vertebrae. J Gerontol 21:537–543

    Google Scholar 

  2. Wakamatsu E, Sissons HA (1969) The cancellous bone of the iliac crest. Calcif Tissue Res 4:147–161

    Google Scholar 

  3. Jaworski ZFG (1971) Some morphologic and dynamic aspects of remodeling on the endosteal-cortical and trabecular surfaces. J Med Sci 7:491–492

    Google Scholar 

  4. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS (1983) Relationship between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanism of bone loss. J Clin Invest 72:1396–1409

    Google Scholar 

  5. Aaron JE, Makins NB, Sagreiya K (1987) The microanatomy of trabecular bone loss in normal aging men and women. Clin Orthop Rel Res 215:260–271

    Google Scholar 

  6. Dempster DW, Shane E, Horbert W, Lindsay R (1986) A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: qualitative observations in normal and osteoporotic subjects. J Bone Miner Res 1:15–22

    Google Scholar 

  7. Kleerekoper M, Villanueva AR, Stanciu J, Rao DS, Parfitt AM (1985) The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int 37:594–597

    Google Scholar 

  8. Weinstein RS, Hudson MS (1987) Decreased trabecular plate thickness and increased trabecular plate spacing contribute to age-related loss of bone. Bone 8:137–142

    Google Scholar 

  9. Christiansen C, Christiansen MS, McNair P, Hagen C, Stacklund KE, Transbol I (1980) Trevention of early postmenopausal bone loss: controlled 2 year study in 315 normal females. Eur J Clin Invest 10:273–279

    Google Scholar 

  10. Recker RR, Saville PD, Heaney RP (1977) Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med 87:649–655

    Google Scholar 

  11. Horsman A (1977) Observations of sequential changes in bone mass in postmenopausal women: a controlled trial of estrogen and calcium therapy. Calcif Tissue Res 22:217–224

    Google Scholar 

  12. Lane JM, Healey JH, Schwartz R, Vigorita VJ, Schneider R, Einhorn TA, Suda M, Robbins WC (1984) Treatment of osteoporosis with sodium fluoride and calcium: effects on vertebral fracture incidence and bone histomorphometry. Orthop Clin North Am 15:729–745

    Google Scholar 

  13. Riggs BL (1983) Treatment of osteoporosis with sodium fluoride: an appraisal. In: Peck WA (ed) Bone Miner Res (Annual 2) Elsevier, Amsterdam, pp 366–393

    Google Scholar 

  14. Eriksen EF, Hodgson SF, Riggs BL (1988) Treatment of osteoporosis with sodium fluoride. In: Riggs BL, Melton LJ III (eds) Osteoporosis: etiology, diagnosis and management. Raven Press, New York, pp 415–432

    Google Scholar 

  15. Quarles LE, Gitelman HF, Drezner MK (1988) Induction of de novo bone formation in the beagle: a novel effect of aluminum. J Clin Invest 81:1056–1066

    Google Scholar 

  16. Parfitt AM (1976) The actions of parathyroid hormone on bone. Relation to bone remodeling and turnover, calcium homeostasis and metabolic bone disease. Metabolism 25:1033–1069

    Google Scholar 

  17. Abdallh H, Hart DM, Lindsay R (1984) Differential bone loss and effect of long-term estrogen therapy according to time of introduction of therapy after oophorectomy. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL (eds) Osteoporosis I. Glostrup Hospital, Copenhagen, pp 587–592

    Google Scholar 

  18. Aloia JF, Vaswani A, Kapoor A, Yeh JK, Cohn SH (1985) Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism 34:124–129

    Google Scholar 

  19. Parfitt AM (1983) The physiologic and clinical significance of bone histomorphometric data. In: Recker RR (ed) Bone histomorphometry: techniques and interpretation. CRC Press, Boca Raton, FL, pp 143–224

    Google Scholar 

  20. Frost HM (1979) Treatment of osteoporoses by manipulation of coherent bone cell populations. Clin Orthop Rel Res 143:227–243

    Google Scholar 

  21. Anderson C, Cape RDT, Crilly RG, Hodsman AB, Wolfe BMJ (1984) Preliminary observation of a form of coherence therapy for osteoporosis. Calcif Tissue Int 36:341–343

    Google Scholar 

  22. Sone K, Tashiro M, Fujinaga T, Tokayama K, Kurome T (1980) Long-term low-dose prostaglandin E1 administration. J Pediatr 97:866–867

    Google Scholar 

  23. Ueda K, Saito A, Nakano H, Aoshima M Yokota M, Muraoka R, Iwaya T (1980) Cortical hyperostosis following long-term administration of prostaglandin E2 in infants with cyanotic congenital heart disease. J Pediatr 97:834–836

    Google Scholar 

  24. Ringel RW, Brenner JI, Haney PH, Burns JE, Moulton AL, German MA (1982) Prostaglandin-induced periostitis: a complication of long-term PGE1 infusion in an infant with congenital heart disease. Radiology 142:657–658

    Google Scholar 

  25. Lund JE, Brown WP, Tregerman L (1982) The toxicology of PGE2. In: Wu KK, Rossi EC (eds) Prostaglandin in clinical medicine: cardiovascular and thrombotic disorders. Yearbook, Medical Publishers, Inc, New York, pp 93–109

    Google Scholar 

  26. Shih MS, Norrdin RW (1987) Effect of PGE2 on regional cortico-endosteal remodeling in beagles with fractured ribs: a histomorphometric study. Bone Miner 3:27–34

    Google Scholar 

  27. High WB (1987) Prostaglandins and bone remodeling. Calcif Tissue Int 41:295–296

    Google Scholar 

  28. Li XJ, Jee WSS, Li LY, Patterson-Buckendahl P (1990) Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs. Bone 11:353–364

    Google Scholar 

  29. Norrdin RW, Shih MS (1988) Systemic effects of prostaglandin E2 on vertebral trabecular remodeling in beagles used in a healing study. Calcif Tissue Int 42:363–368

    Google Scholar 

  30. Ueno K, Woodbury DM, Haba T, Price P, Anderson R, Jee WSS (1984) The effects of prostaglandin E2 in growing rats: depressed longitudinal and radial growth and increased metaphyseal hard tissue mass. Bone 6:79–86

    Google Scholar 

  31. Jee WSS Ueno K, Deng YP, Woodbury DM (1985) The effects of prostaglandin E2 in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation. Calcif Tissue Int 37:148–157

    Google Scholar 

  32. Jee WSS, Ueno K, Kimmel DB, Woodbury DM, Price P, Woodbury LA (1987) The role of bone cells in increasing hard tissue in rapidly growing rats treated with prostaglandin E2. Bone 8:171–178

    Google Scholar 

  33. Furuta Y, Jee WSS (1986) The effect of 16, 16-dimethylprostaglandin E2 on weanling rat skeleton: chronic and systemic administration. Anat Rec 215:305–316

    Google Scholar 

  34. Saville PD (1969) Changes in skeletal mass and fragility with castration in the rat: a model of osteoporosis. J Am Geriatr Soc 17:155–166

    Google Scholar 

  35. Kalu DN, Hardin RR, Cockerham R (1984) Evaluation of the pathogenesis of skeletal changes in ovariectomized rats. Endocrinology 115:507–512

    Google Scholar 

  36. Tabuchi C, Simmons DJ, Fausto A, Russell J, Binderman I, Avioli L (1986) Bone deficit in ovariectomized rats: functional contribution of the marrow stromal cell population and the effect of oral dihydrotrachysterol treatment. J Clin Invest 78:637–642

    Google Scholar 

  37. Wronski TJ, Walsh CC, Ignaszewski LA (1986) Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone 7:119–123

    Google Scholar 

  38. Turner RT, Vandersteenhoven JJ, Bell NH (1987) The effects of ovariectomy and 17β-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 2:115–122

    Google Scholar 

  39. Hori M, Uzawa T, Morita K, Noda T, Takahashi H, Inoue J (1987) Effect of human parathyroid hormone (PTH[1–34]) on experimental osteopenia of rats induced by ovariectomy. Bone Miner 3:193–199

    Google Scholar 

  40. Wronski TJ, Clintron M, Dann LM (1988) Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43:179–183

    Google Scholar 

  41. Mori S, Jee WSS, Li XJ, Chan S, Kimmel DB (1990) Effects of prostaglandin E2 on production of new cancellous bone in the axial skeleton of ovariectomized rats. Bone 11:103–113

    Google Scholar 

  42. Waynforth HB (1980) Experimental and surgical technique in the rat. Academic Press, New York

    Google Scholar 

  43. Henry JB (1974) Clinical chemistry. In: Davidsohn I, Henry JB (eds) Clinical diagnosis and management by laboratory methods. WB Saunders, Philadelphia, PA.

    Google Scholar 

  44. Patterson-Allen P, Brautigam CE, Grindeland RE, Asling CW, Callahan PX (1982) A specific radioimmunoassay for osteocalcin with advantageous species cross reactivity. Anal Biochem 120:1–7

    Google Scholar 

  45. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Committee. J Bone Miner Res 2:595–610

    Google Scholar 

  46. Frost HM (1983) Bone histomorphometry: analysis of trabecular bone dynamics. In: Recker RR (ed) Bone histomorphometry: techniques and interpretation. CRC Press Boca Raton, FL, pp 109–142

    Google Scholar 

  47. Recker RR, Kimmel DB, Parfitt AM, Davies KM, Keshawarz N, Kinders S (1988) Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res, 3:133–144

    Google Scholar 

  48. Sokal R, Rohlf FJ (1969) Biometry. Freeman, San Francisco

    Google Scholar 

  49. Hauschka PV, Lian TB, Gallop PM (1975) Direct identification of the calcium binding amino acid γ-carboxyglutamate in mineralized tissue. Proc Natl Acad Sci 72:3925–3929

    Google Scholar 

  50. Price P (1983) Osteocalcin. In: Peck WA (ed) Bone and mineral research, Annual 1, Chapter 4. Excerpta Medica, Amsterdam, pp 155–190

    Google Scholar 

  51. Deptos LJ, Catherwood BD (1983) BGP and bone metabolism. In: Frame B, Potts JT Jr (eds) Clinical disorders of bone and mineral metabolism, Chapter 4, Excerpta Medica, Amsterdam

    Google Scholar 

  52. Garcia-Carrasco M, Gruson M, de Vernejoul C, Dewne MA, Miravet L (1988) Osteocalcin and bone morphometric parameters in adults without bone disease. Calcif Tissue Int 42:13–17

    Google Scholar 

  53. Krane SM (1977) Paget's disease of bone. Clin Orthop 127:24–26

    Google Scholar 

  54. Delmas DD, Stenner D, Wahner HW, Mann KG, Riggs L (1983) Increase in serum bone γ-carboxyglutamic acid protein with aging in women: implications for the mechanisms of age-related bone loss. J Clin Invest 71:1316–1321

    Google Scholar 

  55. Delmas DD (1988) Biochemical markers of bone turnover in osteoporosis. In: Riggs BL, Melton LJ (eds) Osteoporosis: etiology, diagnosis and management. Raven Press, New York, pp 302–312

    Google Scholar 

  56. Jee WSS, Mori S, Li XJ, Chan S (1990) Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats. Bone 11:253–266

    Google Scholar 

  57. Nefussi JR, Baron R (1985) PGE2 stimulates both resorption and formation of bone in vitro: differential responses of the periosteum and the endosteum in fetal rat long bone cultures. Anat Rec 211:9–16

    Google Scholar 

  58. Peck WA, Woods WL (1988) The cells of bone. In: Riggs BL, Melton LJ (eds) Osteoporosis: etiology, diagnosis and management. Raven Press, New York, pp 17–19

    Google Scholar 

  59. Recker RR, Heaney RP, Saville PD (1977) The effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med 87:649–655

    Google Scholar 

  60. Snow GR, Anderson C (1986) The effects of 17β-estradiol and progestogen on trabecular bone remodeling in oophorectomized dogs. Calcif Tissue Int 39:198–205

    Google Scholar 

  61. Dannucci GA, Martin RB, Patterson-Buckendahl P (1987) Ovariectomy and trabecular bone remodeling in the dog. Calcif Tissue Int 40:194–199

    Google Scholar 

  62. Lindsay R (1988) Sex steroids in the pathogenesis and prevention of osteoporosis. In: Riggs BL, Melton LJ (eds) Osteoporosis: etiology, diagnosis and management. Raven Press, New York, pp 342–347

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Radiobiology, University of Utah School of Medicine, Building 586, 84112, Salt Lake City, Utah, USA

    S. Mori, W. S. S. Jee & X. J. Li

Authors
  1. S. Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. S. S. Jee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X. J. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mori, S., Jee, W.S.S. & Li, X.J. Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2 . Calcif Tissue Int 50, 80–87 (1992). https://doi.org/10.1007/BF00297302

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00297302

Key words

Search

Navigation